

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lipopolysaccharide biosynthetic process (GO:0009103) | 9.07350801 |
| 2 | lipopolysaccharide metabolic process (GO:0008653) | 8.19980962 |
| 3 | protein-chromophore linkage (GO:0018298) | 7.29206125 |
| 4 | regulation of protein glycosylation (GO:0060049) | 6.95070204 |
| 5 | DNA methylation involved in gamete generation (GO:0043046) | 6.84060735 |
| 6 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 6.77426669 |
| 7 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 6.52747215 |
| 8 | regulation of meiosis I (GO:0060631) | 6.28334133 |
| 9 | phenol-containing compound catabolic process (GO:0019336) | 5.66389622 |
| 10 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.32674109 |
| 11 | sulfate transmembrane transport (GO:1902358) | 5.32444863 |
| 12 | positive regulation of developmental pigmentation (GO:0048087) | 5.28621491 |
| 13 | regulation of pigment cell differentiation (GO:0050932) | 5.26415104 |
| 14 | negative regulation of glycoprotein metabolic process (GO:1903019) | 5.12080354 |
| 15 | piRNA metabolic process (GO:0034587) | 5.09220471 |
| 16 | hormone catabolic process (GO:0042447) | 5.06827795 |
| 17 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.01762891 |
| 18 | germinal center formation (GO:0002467) | 4.78733524 |
| 19 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.54403805 |
| 20 | sulfate transport (GO:0008272) | 4.26511758 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.21097889 |
| 22 | L-phenylalanine catabolic process (GO:0006559) | 4.21097889 |
| 23 | SMAD protein complex assembly (GO:0007183) | 4.16979608 |
| 24 | thyroid hormone generation (GO:0006590) | 4.05508743 |
| 25 | tyrosine metabolic process (GO:0006570) | 4.02072492 |
| 26 | positive regulation of meiosis (GO:0045836) | 3.85416374 |
| 27 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.71815184 |
| 28 | regulation of platelet aggregation (GO:0090330) | 3.67041841 |
| 29 | heme transport (GO:0015886) | 3.66549770 |
| 30 | negative regulation of stem cell proliferation (GO:2000647) | 3.64124678 |
| 31 | cellular modified amino acid catabolic process (GO:0042219) | 3.55531713 |
| 32 | positive regulation of meiotic cell cycle (GO:0051446) | 3.52280502 |
| 33 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.49261895 |
| 34 | meiotic chromosome segregation (GO:0045132) | 3.45056523 |
| 35 | cellular response to zinc ion (GO:0071294) | 3.42950839 |
| 36 | serotonin receptor signaling pathway (GO:0007210) | 3.42662585 |
| 37 | thyroid hormone metabolic process (GO:0042403) | 3.40487211 |
| 38 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.39525465 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 3.37050671 |
| 40 | paraxial mesoderm development (GO:0048339) | 3.34648210 |
| 41 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.34082862 |
| 42 | notochord development (GO:0030903) | 3.24863326 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.24200386 |
| 44 | L-phenylalanine metabolic process (GO:0006558) | 3.24200386 |
| 45 | response to mercury ion (GO:0046689) | 3.16908718 |
| 46 | urate metabolic process (GO:0046415) | 3.10110939 |
| 47 | rhodopsin mediated signaling pathway (GO:0016056) | 3.08281310 |
| 48 | protein retention in ER lumen (GO:0006621) | 3.06185826 |
| 49 | DNA deamination (GO:0045006) | 3.04857025 |
| 50 | thrombin receptor signaling pathway (GO:0070493) | 3.02125975 |
| 51 | aromatic amino acid family catabolic process (GO:0009074) | 3.00082924 |
| 52 | postsynaptic membrane organization (GO:0001941) | 2.99009768 |
| 53 | pantothenate metabolic process (GO:0015939) | 2.90265539 |
| 54 | response to epinephrine (GO:0071871) | 2.88099550 |
| 55 | glycerol metabolic process (GO:0006071) | 2.87606300 |
| 56 | cellular biogenic amine catabolic process (GO:0042402) | 2.85395667 |
| 57 | amine catabolic process (GO:0009310) | 2.85395667 |
| 58 | positive regulation of fatty acid oxidation (GO:0046321) | 2.83706197 |
| 59 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.80910884 |
| 60 | regulation of platelet activation (GO:0010543) | 2.77878145 |
| 61 | cellular response to gamma radiation (GO:0071480) | 2.75777021 |
| 62 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.74556390 |
| 63 | protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205) | 2.74535035 |
| 64 | tachykinin receptor signaling pathway (GO:0007217) | 2.73791738 |
| 65 | regulation of odontogenesis (GO:0042481) | 2.69787843 |
| 66 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.67073290 |
| 67 | regulation of gonadotropin secretion (GO:0032276) | 2.64865800 |
| 68 | lysine metabolic process (GO:0006553) | 2.61345207 |
| 69 | lysine catabolic process (GO:0006554) | 2.61345207 |
| 70 | vitamin transmembrane transport (GO:0035461) | 2.59418991 |
| 71 | heart valve formation (GO:0003188) | 2.58873485 |
| 72 | uterus development (GO:0060065) | 2.58331322 |
| 73 | regulation of interleukin-5 production (GO:0032674) | 2.55894960 |
| 74 | iron coordination entity transport (GO:1901678) | 2.54773692 |
| 75 | response to interferon-beta (GO:0035456) | 2.54186257 |
| 76 | positive regulation of mast cell activation (GO:0033005) | 2.53814516 |
| 77 | polyol biosynthetic process (GO:0046173) | 2.53148584 |
| 78 | centriole replication (GO:0007099) | 2.52844647 |
| 79 | regulation of metanephros development (GO:0072215) | 2.49436858 |
| 80 | aspartate family amino acid catabolic process (GO:0009068) | 2.47135101 |
| 81 | toxin metabolic process (GO:0009404) | 2.45321846 |
| 82 | positive regulation of mast cell degranulation (GO:0043306) | 2.42824899 |
| 83 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.42824899 |
| 84 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.41849109 |
| 85 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.40371431 |
| 86 | alditol metabolic process (GO:0019400) | 2.39142188 |
| 87 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.38380529 |
| 88 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.38371966 |
| 89 | aromatic amino acid family metabolic process (GO:0009072) | 2.38366851 |
| 90 | membrane lipid biosynthetic process (GO:0046467) | 2.36771903 |
| 91 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.35233494 |
| 92 | response to folic acid (GO:0051593) | 2.34664524 |
| 93 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.33562203 |
| 94 | sulfur compound transport (GO:0072348) | 2.33308706 |
| 95 | xenobiotic catabolic process (GO:0042178) | 2.32871542 |
| 96 | indolalkylamine metabolic process (GO:0006586) | 2.31946718 |
| 97 | regulation of cell adhesion mediated by integrin (GO:0033628) | 2.27892489 |
| 98 | sphingosine metabolic process (GO:0006670) | 13.4086980 |
| 99 | diol metabolic process (GO:0034311) | 12.0077274 |
| 100 | sphingoid metabolic process (GO:0046519) | 10.7504001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AR_21572438_ChIP-Seq_LNCaP_Human | 4.09551556 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.47524159 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.44346075 |
| 4 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.31002243 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.75853743 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.68426756 |
| 7 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60676981 |
| 8 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.59169464 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.46084038 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.40514713 |
| 11 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.37375786 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.17261987 |
| 13 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.03038821 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.96193622 |
| 15 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.93583477 |
| 16 | P300_19829295_ChIP-Seq_ESCs_Human | 1.80632288 |
| 17 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.80387121 |
| 18 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.80387121 |
| 19 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.80052265 |
| 20 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.76441020 |
| 21 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67839758 |
| 22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.66897614 |
| 23 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.65974123 |
| 24 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.64537552 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64084689 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.63585964 |
| 27 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.61664999 |
| 28 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56443807 |
| 29 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.56443807 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55789853 |
| 31 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.55214180 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54777553 |
| 33 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.53254262 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.51792499 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45122451 |
| 36 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.42749557 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39928444 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38679990 |
| 39 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.35551138 |
| 40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.34504847 |
| 41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34146139 |
| 42 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.33988037 |
| 43 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33738970 |
| 44 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.33094631 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.31883317 |
| 46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.31773075 |
| 47 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.30140351 |
| 48 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.29680588 |
| 49 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27933792 |
| 50 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26486754 |
| 51 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.26108964 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24944464 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24707169 |
| 54 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.23533335 |
| 55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23371278 |
| 56 | TCF4_23295773_ChIP-Seq_U87_Human | 1.23360900 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23200725 |
| 58 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.23147098 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21825455 |
| 60 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21176857 |
| 61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20567039 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17829011 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15468097 |
| 64 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.13277307 |
| 65 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.12955939 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10766356 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10167479 |
| 68 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09516001 |
| 69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08310480 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07622245 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06711672 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06640279 |
| 73 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06261856 |
| 74 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05798628 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05438536 |
| 76 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03452746 |
| 77 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.02427547 |
| 78 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00351961 |
| 79 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99999040 |
| 80 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99723938 |
| 81 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99723938 |
| 82 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98266514 |
| 83 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.97243199 |
| 84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96781780 |
| 85 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96556287 |
| 86 | GATA3_26560356_Chip-Seq_TH1_Human | 0.95901031 |
| 87 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.95845426 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94786836 |
| 89 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94603451 |
| 90 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.94077588 |
| 91 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.93861295 |
| 92 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93703553 |
| 93 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93617780 |
| 94 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93501474 |
| 95 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.93478176 |
| 96 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.91882399 |
| 97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91204167 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90797769 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89920712 |
| 100 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.89202344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 7.45633238 |
| 2 | MP0003136_yellow_coat_color | 7.10020235 |
| 3 | MP0005171_absent_coat_pigmentation | 6.96923827 |
| 4 | MP0002653_abnormal_ependyma_morphology | 5.34402621 |
| 5 | MP0003045_fibrosis | 4.39195477 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.84427273 |
| 7 | MP0003646_muscle_fatigue | 3.33891029 |
| 8 | MP0003890_abnormal_embryonic-extraembry | 2.54917889 |
| 9 | MP0004381_abnormal_hair_follicle | 2.53881037 |
| 10 | MP0003879_abnormal_hair_cell | 2.39640154 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.34652805 |
| 12 | MP0005670_abnormal_white_adipose | 2.22178523 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.18503832 |
| 14 | MP0006054_spinal_hemorrhage | 2.13405888 |
| 15 | MP0005464_abnormal_platelet_physiology | 1.90347893 |
| 16 | MP0000749_muscle_degeneration | 1.87647705 |
| 17 | MP0002168_other_aberrant_phenotype | 1.77444700 |
| 18 | MP0005075_abnormal_melanosome_morpholog | 1.73922032 |
| 19 | MP0004147_increased_porphyrin_level | 1.70347270 |
| 20 | MP0005174_abnormal_tail_pigmentation | 1.49803675 |
| 21 | MP0002736_abnormal_nociception_after | 1.49059332 |
| 22 | MP0005365_abnormal_bile_salt | 1.48483873 |
| 23 | MP0003011_delayed_dark_adaptation | 1.45373186 |
| 24 | MP0009764_decreased_sensitivity_to | 1.41470929 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.36854373 |
| 26 | MP0004043_abnormal_pH_regulation | 1.36089593 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.24368572 |
| 28 | MP0002095_abnormal_skin_pigmentation | 1.23837267 |
| 29 | MP0002735_abnormal_chemical_nociception | 1.20090983 |
| 30 | MP0003724_increased_susceptibility_to | 1.19048762 |
| 31 | MP0002938_white_spotting | 1.17349789 |
| 32 | MP0003868_abnormal_feces_composition | 1.14957538 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.12340746 |
| 34 | MP0008004_abnormal_stomach_pH | 1.08248172 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.07093699 |
| 36 | MP0002638_abnormal_pupillary_reflex | 0.99367902 |
| 37 | MP0003252_abnormal_bile_duct | 0.99078349 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 0.96718104 |
| 39 | MP0000383_abnormal_hair_follicle | 0.95848677 |
| 40 | MP0001984_abnormal_olfaction | 0.95455381 |
| 41 | MP0008872_abnormal_physiological_respon | 0.95230527 |
| 42 | MP0005395_other_phenotype | 0.93203514 |
| 43 | MP0002160_abnormal_reproductive_system | 0.92875542 |
| 44 | MP0008569_lethality_at_weaning | 0.92333999 |
| 45 | MP0001968_abnormal_touch/_nociception | 0.91711941 |
| 46 | MP0001970_abnormal_pain_threshold | 0.89745596 |
| 47 | MP0002733_abnormal_thermal_nociception | 0.89527410 |
| 48 | MP0003195_calcinosis | 0.88388365 |
| 49 | MP0001661_extended_life_span | 0.88347738 |
| 50 | MP0010329_abnormal_lipoprotein_level | 0.87729967 |
| 51 | MP0000015_abnormal_ear_pigmentation | 0.86754948 |
| 52 | MP0000427_abnormal_hair_cycle | 0.86249048 |
| 53 | MP0001835_abnormal_antigen_presentation | 0.84347273 |
| 54 | MP0001800_abnormal_humoral_immune | 0.84002402 |
| 55 | MP0005410_abnormal_fertilization | 0.83827134 |
| 56 | MP0002075_abnormal_coat/hair_pigmentati | 0.79380572 |
| 57 | MP0002132_abnormal_respiratory_system | 0.78691891 |
| 58 | MP0002254_reproductive_system_inflammat | 0.77481998 |
| 59 | MP0001324_abnormal_eye_pigmentation | 0.71384556 |
| 60 | MP0004233_abnormal_muscle_weight | 0.70161515 |
| 61 | MP0002452_abnormal_antigen_presenting | 0.68208266 |
| 62 | MP0005319_abnormal_enzyme/_coenzyme | 0.67520901 |
| 63 | MP0002269_muscular_atrophy | 0.63452064 |
| 64 | MP0002419_abnormal_innate_immunity | 0.62825197 |
| 65 | MP0000230_abnormal_systemic_arterial | 0.62415094 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 0.62167715 |
| 67 | MP0005646_abnormal_pituitary_gland | 0.61872760 |
| 68 | MP0003186_abnormal_redox_activity | 0.60988725 |
| 69 | MP0001845_abnormal_inflammatory_respons | 0.60936321 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 0.60773233 |
| 71 | MP0008469_abnormal_protein_level | 0.60476896 |
| 72 | MP0008874_decreased_physiological_sensi | 0.59642353 |
| 73 | MP0002332_abnormal_exercise_endurance | 0.58921959 |
| 74 | MP0004484_altered_response_of | 0.57938485 |
| 75 | MP0005076_abnormal_cell_differentiation | 0.57840509 |
| 76 | MP0001790_abnormal_immune_system | 0.57339661 |
| 77 | MP0005387_immune_system_phenotype | 0.57339661 |
| 78 | MP0005000_abnormal_immune_tolerance | 0.57030689 |
| 79 | MP0002148_abnormal_hypersensitivity_rea | 0.56733641 |
| 80 | MP0009763_increased_sensitivity_to | 0.56257450 |
| 81 | MP0003303_peritoneal_inflammation | 0.56244989 |
| 82 | MP0002723_abnormal_immune_serum | 0.54530228 |
| 83 | MP0003137_abnormal_impulse_conducting | 0.53724816 |
| 84 | MP0003279_aneurysm | 0.53057963 |
| 85 | MP0000343_altered_response_to | 0.52087897 |
| 86 | MP0005389_reproductive_system_phenotype | 0.51932172 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.50707580 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.50462935 |
| 89 | MP0005025_abnormal_response_to | 0.50027189 |
| 90 | MP0002272_abnormal_nervous_system | 0.47428186 |
| 91 | MP0004130_abnormal_muscle_cell | 0.47381482 |
| 92 | MP0000920_abnormal_myelination | 0.46076305 |
| 93 | MP0002971_abnormal_brown_adipose | 0.44178001 |
| 94 | MP0002420_abnormal_adaptive_immunity | 0.43999330 |
| 95 | MP0002722_abnormal_immune_system | 0.42726104 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.42554119 |
| 97 | MP0001486_abnormal_startle_reflex | 0.42074596 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.41303797 |
| 99 | MP0003075_altered_response_to | 0.40446960 |
| 100 | MP0002118_abnormal_lipid_homeostasis | 0.39856689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Amelogenesis imperfecta (HP:0000705) | 7.67177029 |
| 2 | Focal motor seizures (HP:0011153) | 7.48228069 |
| 3 | Acanthocytosis (HP:0001927) | 6.69067185 |
| 4 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 6.51356228 |
| 5 | Parakeratosis (HP:0001036) | 5.73247185 |
| 6 | Spontaneous hematomas (HP:0007420) | 5.46099415 |
| 7 | Petechiae (HP:0000967) | 5.35724177 |
| 8 | Hematochezia (HP:0002573) | 5.02057128 |
| 9 | Ulnar claw (HP:0001178) | 4.43625804 |
| 10 | Conjunctival telangiectasia (HP:0000524) | 4.39249537 |
| 11 | Aplastic anemia (HP:0001915) | 4.19204755 |
| 12 | Purpura (HP:0000979) | 4.06950164 |
| 13 | Rectal prolapse (HP:0002035) | 3.94997785 |
| 14 | Albinism (HP:0001022) | 3.85420682 |
| 15 | Dialeptic seizures (HP:0011146) | 3.78727788 |
| 16 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.76947897 |
| 17 | Poikilocytosis (HP:0004447) | 3.65423174 |
| 18 | Erythroderma (HP:0001019) | 3.30410867 |
| 19 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.28321417 |
| 20 | Prolonged bleeding time (HP:0003010) | 3.25517608 |
| 21 | Colon cancer (HP:0003003) | 3.23670798 |
| 22 | Focal seizures (HP:0007359) | 3.19818400 |
| 23 | Difficulty walking (HP:0002355) | 3.14427393 |
| 24 | Vertebral arch anomaly (HP:0008438) | 3.04470598 |
| 25 | Proximal amyotrophy (HP:0007126) | 3.02386618 |
| 26 | Abnormality of the vocal cords (HP:0008777) | 3.01962274 |
| 27 | Epistaxis (HP:0000421) | 3.00584864 |
| 28 | Esophageal varix (HP:0002040) | 2.88494590 |
| 29 | Progressive inability to walk (HP:0002505) | 2.74466941 |
| 30 | Menorrhagia (HP:0000132) | 2.73806781 |
| 31 | Autoimmune hemolytic anemia (HP:0001890) | 2.73623200 |
| 32 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.72539524 |
| 33 | Hypoplastic iliac wings (HP:0002866) | 2.55300800 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.50094745 |
| 35 | Portal hypertension (HP:0001409) | 2.49111854 |
| 36 | Scapular winging (HP:0003691) | 2.46568950 |
| 37 | Gangrene (HP:0100758) | 2.45524339 |
| 38 | Potter facies (HP:0002009) | 2.42374860 |
| 39 | Facial shape deformation (HP:0011334) | 2.42374860 |
| 40 | Hyperlipoproteinemia (HP:0010980) | 2.38327329 |
| 41 | Pancreatic cysts (HP:0001737) | 2.37290569 |
| 42 | Broad ribs (HP:0000885) | 2.36150379 |
| 43 | Retinitis pigmentosa (HP:0000510) | 2.32104139 |
| 44 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.31551452 |
| 45 | Abnormality of the renal cortex (HP:0011035) | 2.30720362 |
| 46 | Type I transferrin isoform profile (HP:0003642) | 2.29947338 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.29630201 |
| 48 | Abnormality of the hepatic vasculature (HP:0006707) | 2.20856932 |
| 49 | IgM deficiency (HP:0002850) | 2.14744932 |
| 50 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14447955 |
| 51 | Microcytic anemia (HP:0001935) | 2.10657217 |
| 52 | Opisthotonus (HP:0002179) | 2.10339514 |
| 53 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.09127020 |
| 54 | Onion bulb formation (HP:0003383) | 2.07219239 |
| 55 | Follicular hyperkeratosis (HP:0007502) | 2.06928572 |
| 56 | Polycythemia (HP:0001901) | 2.06723702 |
| 57 | Gingival bleeding (HP:0000225) | 2.05474018 |
| 58 | Neonatal respiratory distress (HP:0002643) | 2.04593041 |
| 59 | Facial diplegia (HP:0001349) | 2.04277564 |
| 60 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.04253017 |
| 61 | Increased cerebral lipofuscin (HP:0011813) | 1.99650233 |
| 62 | Peripheral hypomyelination (HP:0007182) | 1.96165942 |
| 63 | Colitis (HP:0002583) | 1.92273672 |
| 64 | Abnormality of the wing of the ilium (HP:0011867) | 1.91788252 |
| 65 | Enlarged kidneys (HP:0000105) | 1.88365773 |
| 66 | Abnormality of the renal medulla (HP:0100957) | 1.88079826 |
| 67 | Pulmonary embolism (HP:0002204) | 1.82799930 |
| 68 | Dehydration (HP:0001944) | 1.82685584 |
| 69 | Chronic diarrhea (HP:0002028) | 1.81785539 |
| 70 | Ulnar bowing (HP:0003031) | 1.81619073 |
| 71 | Recurrent sinusitis (HP:0011108) | 1.80717545 |
| 72 | Abnormal platelet volume (HP:0011876) | 1.80541252 |
| 73 | Abnormality of macular pigmentation (HP:0008002) | 1.79059231 |
| 74 | Acute hepatic failure (HP:0006554) | 1.78752903 |
| 75 | Asymmetric septal hypertrophy (HP:0001670) | 1.77393432 |
| 76 | Abnormality of binocular vision (HP:0011514) | 1.76782137 |
| 77 | Diplopia (HP:0000651) | 1.76782137 |
| 78 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.75307833 |
| 79 | Ileus (HP:0002595) | 1.74925428 |
| 80 | Radial bowing (HP:0002986) | 1.74877149 |
| 81 | Increased mean platelet volume (HP:0011877) | 1.74199321 |
| 82 | Lack of skin elasticity (HP:0100679) | 1.73151138 |
| 83 | Hypoplasia of the odontoid process (HP:0003311) | 1.71553537 |
| 84 | Renal tubular acidosis (HP:0001947) | 1.71425710 |
| 85 | Tubulointerstitial fibrosis (HP:0005576) | 1.71351207 |
| 86 | Stomatitis (HP:0010280) | 1.70312814 |
| 87 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.67314517 |
| 88 | Congenital stationary night blindness (HP:0007642) | 1.66908269 |
| 89 | Severe visual impairment (HP:0001141) | 1.66416542 |
| 90 | Synostosis involving bones of the feet (HP:0009140) | 1.65989209 |
| 91 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.65989209 |
| 92 | Synostosis of carpal bones (HP:0005048) | 1.64680738 |
| 93 | Inability to walk (HP:0002540) | 1.63501235 |
| 94 | Spastic paraparesis (HP:0002313) | 1.63433084 |
| 95 | Hypoproteinemia (HP:0003075) | 1.63200656 |
| 96 | Hemoptysis (HP:0002105) | 1.62889767 |
| 97 | Hematuria (HP:0000790) | 1.62631903 |
| 98 | Steppage gait (HP:0003376) | 1.59244596 |
| 99 | Nonprogressive disorder (HP:0003680) | 1.59147059 |
| 100 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.58694573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 9.66021433 |
| 2 | STK38L | 6.71821530 |
| 3 | LATS2 | 6.08170822 |
| 4 | STK38 | 2.85907295 |
| 5 | ACVR1B | 2.58223511 |
| 6 | FRK | 2.48843890 |
| 7 | NLK | 2.29483877 |
| 8 | PRKD3 | 2.24183498 |
| 9 | KSR2 | 2.10225349 |
| 10 | MAP2K2 | 2.01092091 |
| 11 | ZAK | 2.01085492 |
| 12 | STK3 | 1.98278385 |
| 13 | BMPR1B | 1.90687577 |
| 14 | PIK3CG | 1.62882522 |
| 15 | TAOK3 | 1.62855014 |
| 16 | MELK | 1.46963317 |
| 17 | MAP3K3 | 1.16025092 |
| 18 | MAP3K2 | 1.14569255 |
| 19 | LMTK2 | 1.00731374 |
| 20 | PRKD1 | 0.99376740 |
| 21 | IRAK3 | 0.98224802 |
| 22 | PRKAA2 | 0.94956575 |
| 23 | PDPK1 | 0.93532072 |
| 24 | EIF2AK3 | 0.91964659 |
| 25 | GRK7 | 0.91171047 |
| 26 | PINK1 | 0.89013130 |
| 27 | TEC | 0.86447476 |
| 28 | DAPK2 | 0.81261567 |
| 29 | KIT | 0.81059855 |
| 30 | ADRBK2 | 0.77624107 |
| 31 | ADRBK1 | 0.75375324 |
| 32 | TNK2 | 0.74405945 |
| 33 | TAOK1 | 0.67919337 |
| 34 | RIPK4 | 0.67571593 |
| 35 | RAF1 | 0.67285372 |
| 36 | MAP2K1 | 0.66629276 |
| 37 | GRK5 | 0.65599933 |
| 38 | PIM2 | 0.65488171 |
| 39 | TGFBR1 | 0.65144876 |
| 40 | IRAK4 | 0.60715385 |
| 41 | PTK2B | 0.60467007 |
| 42 | CSF1R | 0.58141516 |
| 43 | BTK | 0.57862430 |
| 44 | MAP4K2 | 0.57321883 |
| 45 | CSNK1A1L | 0.57285449 |
| 46 | FES | 0.56189734 |
| 47 | TGFBR2 | 0.52112283 |
| 48 | CSK | 0.49683286 |
| 49 | ERN1 | 0.49052151 |
| 50 | JAK3 | 0.47136856 |
| 51 | JAK2 | 0.44838145 |
| 52 | STK11 | 0.43490687 |
| 53 | NEK9 | 0.42567423 |
| 54 | HCK | 0.42334511 |
| 55 | TXK | 0.41688725 |
| 56 | MAP2K3 | 0.41009651 |
| 57 | PLK2 | 0.40973552 |
| 58 | PRKG2 | 0.40081398 |
| 59 | ITK | 0.38974053 |
| 60 | MAP4K1 | 0.38792423 |
| 61 | TYK2 | 0.38031911 |
| 62 | MATK | 0.37860817 |
| 63 | MAPKAPK3 | 0.37667915 |
| 64 | SYK | 0.36190209 |
| 65 | MOS | 0.34571706 |
| 66 | GRK6 | 0.33910173 |
| 67 | FGR | 0.33468319 |
| 68 | PAK3 | 0.33437753 |
| 69 | PAK6 | 0.33327546 |
| 70 | MAPK13 | 0.31226494 |
| 71 | IKBKB | 0.30325863 |
| 72 | LYN | 0.29088086 |
| 73 | NEK2 | 0.28612537 |
| 74 | ABL1 | 0.27935585 |
| 75 | NME1 | 0.27752497 |
| 76 | MAP3K1 | 0.27719522 |
| 77 | GRK1 | 0.27258042 |
| 78 | PRKCE | 0.26337323 |
| 79 | PIM1 | 0.25259294 |
| 80 | KSR1 | 0.24759267 |
| 81 | IRAK1 | 0.24065867 |
| 82 | STK24 | 0.24040427 |
| 83 | BLK | 0.23371706 |
| 84 | BMX | 0.22237999 |
| 85 | MAPK3 | 0.21884625 |
| 86 | ARAF | 0.21206370 |
| 87 | TAOK2 | 0.18049741 |
| 88 | BCKDK | 0.16969006 |
| 89 | FER | 0.16620537 |
| 90 | PRKACA | 0.16454529 |
| 91 | PRKACG | 0.16153790 |
| 92 | RET | 0.14930993 |
| 93 | IKBKE | 0.14874208 |
| 94 | NTRK3 | 0.12519406 |
| 95 | CSNK1D | 0.12419993 |
| 96 | ZAP70 | 0.12112458 |
| 97 | PRKCI | 0.09257713 |
| 98 | LCK | 0.09075777 |
| 99 | TAF1 | 0.08074461 |
| 100 | FLT3 | 0.07465974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 6.34760047 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 3.90336435 |
| 3 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.57436853 |
| 4 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.52831265 |
| 5 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.26331810 |
| 6 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.92838330 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.33524163 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.28836408 |
| 9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.97010612 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.85046621 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.79105445 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 1.75446975 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.65295661 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56060114 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54185372 |
| 16 | Platelet activation_Homo sapiens_hsa04611 | 1.41433226 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.39986648 |
| 18 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.39645102 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.35392352 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35046067 |
| 21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.31467872 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31234025 |
| 23 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.15760858 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12952077 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12228907 |
| 26 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12072656 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.11562999 |
| 28 | GABAergic synapse_Homo sapiens_hsa04727 | 1.11086350 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10076039 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.08494108 |
| 31 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.07400963 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.06614367 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.05445740 |
| 34 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.05292910 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01967538 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01308805 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.00300419 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98006543 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94038882 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.91065819 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.88242853 |
| 42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86871557 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85265773 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84234822 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81904854 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79459950 |
| 47 | Olfactory transduction_Homo sapiens_hsa04740 | 0.75907433 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74837749 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71835788 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71792431 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68584083 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.68494452 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66663806 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66599845 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.64988221 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64953416 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58206453 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57041369 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 0.56634606 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56115031 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55817914 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55435971 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55306219 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54471765 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.53754318 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51048399 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50987848 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.50913694 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49456322 |
| 70 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45740480 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44887182 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44548138 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42853694 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42091421 |
| 75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.40080396 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39636098 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38964140 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38918576 |
| 79 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34405899 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.33573452 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32914316 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.32603050 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32529846 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32174479 |
| 85 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31156368 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31151146 |
| 87 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30997196 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30414019 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.30043184 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.29914459 |
| 91 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.29819382 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.28565060 |
| 93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.26257513 |
| 94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.25630742 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25474900 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25213378 |
| 97 | Gap junction_Homo sapiens_hsa04540 | 0.25085344 |
| 98 | Allograft rejection_Homo sapiens_hsa05330 | 0.24275485 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22938935 |
| 100 | Leishmaniasis_Homo sapiens_hsa05140 | 0.21527287 |

